Citizens Reiterates Market Outperform on Nuvation Bio, Maintains $10 Price Target

Citizens analyst Silvan Turkcan has reiterated a Market Outperform rating on Nuvation Bio (NYSE: NUVB) and has maintained a price target of $10 for the stock.